Import Alert 66-78

(Note: This import alert represents the Agency's current guidance to FDA field personnel regarding the manufacturer(s) and/or products(s) at issue. It does not create or confer any rights for or on any person, and does not operate to bind FDA or the public).

Import Alert # 66-78
Published Date: 10/09/2020
Type: DWPE

Import Alert Name:

"Detention Without Physical Examination of Drugs, Based Upon Analytic Test Results"

Reason for Alert:

Revision of this Import Alert dated 7/22/2020 adds an additional PAF and language regarding the release of individual shipments. This revision does not change the current firms/products listed on the Red List of this Import Alert. Changes are bracketed by asterisks (***).

The Food and Drug Administration (FDA) collects and analyzes samples of drugs, including finished dosage drug products and active pharmaceutical ingredients, considered at risk for adulteration that pose a health risk due to contamination, substandard quality, or ingredient substitution. Detention without physical examination may be appropriate when analytical test results reveal a potential health risk.

Guidance:

Divisions may detain without physical examination (DWPE) shipments of the drugs that appear to be adulterated, listed on the Red List of this Import Alert.

NOTE: This Import Alert does not apply to contamination in drugs based on microbial test results. Please refer to Import Alert 55-05.

Recommendations for addition to DWPE of drugs not listed on the Red List should be forwarded to DIO Import Compliance Branch for review. Recommendations should include background information, analytical worksheets, product labeling, and entry documents. DIO will coordinate the review of the DWPE recommendation to CDER/OC/ODSIR/DGDDP/IECB for consideration.

Release of Articles Subject to Detention Without Physical Examination Under This Import Alert:

DWPE of the drugs listed on the Red List of this Import Alert remains in effect until such time as FDA is satisfied that the appearance of a violation has been removed.

In order to secure release of an individual shipment subject to DWPE under this Import Alert, the importer and/or another responsible party to the shipment should provide evidence that the shipment does not contain drugs that appear to be adulterated. *** CDER/OC/ODSIR/DGDDP/IECB will evaluate on a case-by-case basis.***

To inform FDA's assessment of these shipments and whether the appearance of a violation has been overcome, the firm may provide documentation, including the results of third-party laboratory analyses of a representative sample, using analytical methods that provide results to demonstrate that the firm has addressed the conditions that gave rise to the appearance of a violation. As part of its evaluation of such laboratory analyses, FDA may consider whether the laboratory has been previously inspected by FDA and found to be in compliance with Current Good Manufacturing Practice (CGMP).

Removal from DWPE (REMOVE FROM RED LIST):

To remove a firm's drugs from the Red List, information should be provided to the Agency to adequately demonstrate that the firm has resolved the conditions that gave rise to the appearance of the violation. The purpose of this is so the agency will have confidence that future entries will be in compliance with the Federal Food Drug and Cosmetic Act. This information may include, but is not limited to, a letter detailing its corrective actions, accompanied by documentation. FDA might also determine that it is appropriate to verify a firm's corrective actions through an inspection prior to the agency considering the appearance of adulteration to be addressed.

Per Chapter 9 of the Regulatory Procedures Manual (RPM), a minimum of five (5) consecutive non-violative commercial shipments may be required before the agency can consider that the appearance of a violation has been overcome. For further guidance on removal from DWPE, refer to FDA's Regulatory Procedures Manual, Chapter 9-8, "Detention without Physical Examination (DWPE)," available at: https://www.fda.gov/media/71776/download

If a firm and/or a representative thereof would like to petition for removal from DWPE under this Import Alert, all relevant information supporting the request should be forwarded to the following address:

Food and Drug Administration
Division of Import Operations
12420 Parklawn Drive, ELEM-3109
Rockville, MD 20857

Or, be sent via email to: Importalerts2@fda.hhs.gov

Requests for removal from DWPE will be referred by DIO to CDER/OC/ODSIR/DGDDP/IECB for evaluation.

Questions or issues involving import operations should be addressed to ORA/DIO (301) 796-0356 or FDAImportsInquiry@fda.hhs.gov.

Questions or issues involving OASIS or PREDICT screening should be addressed to ORA/DSS/Import Systems Branch at oraoismdssimpcomplsysbr@fda.hhs.gov.

Questions or issues involving science policy, analysis, preparation, or analytical methodology, should be addressed to ORA/Office of Regulatory Science at oraorsprivatelabimportalerts@fda.hhs.gov

For questions regarding performance standards or other compliance issues regarding drugs subject to this Import Alert, please contact CDER/OC/ODSIR/DGDDP/IECB via email: CDERImportsExports@fda.hhs.gov.

Product Description:

Various Drugs (refer to Red List)

Charge:

For finished dosage drug products and active pharmaceutical ingredients that appear to be adulterated due to harmful impurities:

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to have been prepared, packed or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health. [Adulteration, Section 501(a)(2)(A)]

OASIS Charge Code - INSANITARY

AND/OR

For finished dosage drug products and active pharmaceutical ingredients that appear to be adulterated due to Current Good Manufacturing Practice violations:

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B). [Adulteration, Section 501(a)(2)(B)]

OASIS Charge Code - DRUG GMPS

AND/OR

For finished dosage drug products and active pharmaceutical ingredients that appear to be adulterated because its strength differs from, or its quality or purity falls below the standard set forth in an official compendium recognized by the FD&C Act:

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to be represented as a drug the name of which is recognized in an official compendium and its strength appears to differ from or its quality or purity appear to fall below the standards set forth in such compendium. [Adulteration, Section 501(b)].

OASIS Charge Code - DR QUALITY

AND/OR

For finished dosage drug products and active pharmaceutical ingredients whose name is not recognized in an official compendium and that appears to be adulterated because its strength differs from, or its quality or purity falls below, that which it purports or is represented to possess:

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the drug appears to be represented as not being recognized in an official compendium and appears its strength differs from or its quality or purity falls below, that which it purports or is represented to possess. [Adulteration, Section 501(c)]

OASIS Charge Code - DR QUALITC

AND/OR

For finished dosage drug products and active pharmaceutical ingredients that appear to be adulterated because they have been mixed or packed therewith so as to reduce quality or strength:

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug that a substance has been mixed or packed with so as to reduce its strength. [Adulteration, 501(d)(1)]

OASIS Charge Code - REDUCED

AND/OR

For finished dosage drug products and active pharmaceutical ingredients that appear to be adulterated because it has been substituted wholly or in part therefor:

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug that a substance has been substituted wholly or in part. [Adulteration, 501(d)(2)]

OASIS Charge Code - SUBSTITUTE

List of firms and their products subject to Detention without Physical Examination (DWPE) under this Import Alert (a.k.a. Red List)


CHINA


Guangzhou Youxing Cosmetic Co., Ltd
Date Published : 10/08/2020
Changhong , No. 14 Shuanghe 2nd Rd; Baiyun , Guangzhou, Guangdong CHINA
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 10/08/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.


GUATEMALA


Genesis Partnership Company SA
Date Published : 09/02/2020
Km 19.5 Carretera Al Pacifico, Bodega 28 , Villa Nueva, Guatemala GUATEMALA
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.


MEXICO


4E Global, S.A.P.I. de C.V.
Date Published : 07/16/2020
Av. Uno Norte No. 15 , Bodega 1F y 1G Parque Industrial Cartagena , Tultitlan, MEXICO
53 J - - 01 Bath Soaps and Detergents (not Antiperspirant) (Personal Cleanliness)
Date Published: 07/16/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

53 J - - 99 Other Personal Cleanliness Products (not Antiperspirant), N.E.C.
Date Published: 07/16/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

AAA Cosmetica, SA de CV
Date Published : 07/07/2020
Calle Recursos Hidraulicos 1 , Pueblo La Loma, Tlalnepantla De Baz , Tlalnepantla, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

80 L - - RJ Disinfectant, Medical Devices
Date Published: 07/13/2020

Desc: All Drug and Drug Products
Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

95 R - - GI Hand Washing Sanitizer, Ultraviolet Hygiene Products, Non-Medical
Date Published: 07/13/2020

Desc: All Drug and Drug Products
Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Albek De Mexico S.A. De C.V.
Date Published : 08/04/2020
Oriente Cuatro No. 11 Nuevo , San Juan Del Rio, MEXICO
53 J - - 99 Other Personal Cleanliness Products (not Antiperspirant), N.E.C.
Date Published: 08/04/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/04/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Asesores en Mantenimiento Hidraulico e Industrial, S.A. de C.V.
Date Published : 09/02/2020
Avenida De La Unidad 100 , Col. Valle De Infonavit 1er. Sector, Monterrey , Monterrey, Nuevo Leon MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Asiaticon, SA de CV
Date Published : 08/11/2020
Conkal No. 62 , Ciudad De Mexico, Estado de Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Botanicals Internacional S.A. de C.V.
Date Published : 08/13/2020
Ave. De La Luz No. 73 , Zona Industrial Parque Industrial La Luz, Cuautitlan Izcalli , Cuautitlan Izcalli, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Broncolin, S.A. de C.V.
Date Published : 07/29/2020
Calle Sur 16 No. 353 , Col. Agricola Oriental, Iztacalco , Ciudad De Mexico, Ciudad de Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/29/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

C&G Laboratorios SA de CV
Date Published : 10/09/2020
Calle Pestalozzi No 415 , Col. Narvarte Poniente, Benito Juarez , Ciudad De Mexico, Ciudad de Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 10/09/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

CORPORATIVO BURELI SA DE CV
Date Published : 09/24/2020
Calle Lazaro Cardenas No. 10 , Col. San Jeronimo, Tepetlacalco , Tlalnepantla, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/24/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

DDI MULTINACIONAL SA DE CV
Date Published : 07/13/2020
Javier Espinoza Mz. 30, Lt. 20 Santa Martha Acatitla , Iztapalapa, MEXICO
53 J - - 99 Other Personal Cleanliness Products (not Antiperspirant), N.E.C.
Date Published: 07/13/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

53 L - - 01 Cleansing (Cold Creams, Cleansing Lotions, Liquids, Pads) (Skin Care Preparations)
Date Published: 07/13/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/13/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

DEPQ Internacional S. de R.L de C.V.
Date Published : 07/31/2020
Calzada De Guadalupe 2830-A , Col. Ciudad Satelite Francisco I Madero, San Luis Potosi , San Luis Potosi, San Luis Potosi MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/31/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

DMM Vission, S.A. de C.V.
Date Published : 09/02/2020
Calle Lago Guija Aguaazul 234 , Col. Agua Azul, Nezahualcoyotl , Ciudad Nezahualcoyotl, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Datsen SA DE CV'
Date Published : 07/15/2020
Avenida Del Sol # 308 , Residencial Galaxias, Centro , Villahermosa, Tabasco MEXICO
53 L - - 01 Cleansing (Cold Creams, Cleansing Lotions, Liquids, Pads) (Skin Care Preparations)
Date Published: 07/15/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

ESTRATEGIA HOSPITALARIA SA DE CV
Date Published : 08/14/2020
Avenida Inglaterra 2684 , Col. Vallarta, Guadalajara , Guadalajara, Jalisco MEXICO
53 L - - 01 Cleansing (Cold Creams, Cleansing Lotions, Liquids, Pads) (Skin Care Preparations)
Date Published: 08/14/2020

Desc: All Drug And Drug Products
Notes:                                                                                                                                                                                                                                                                                                                                                

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

60 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

61 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

62 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

63 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

64 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

65 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

66 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products;                                                                                                                                                                                                                                                                                                                                                

Eskbiochem SA de CV
Date Published : 07/15/2020
Av. Japon Mexico No. 412 Bod. 50 Ciudad Industrial , Celaya, Guanajuato MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

GRUPO YACANA MEXICO SAS DE CV
Date Published : 08/20/2020
Avenida Alfonso Reyes 714 , Fracc. Contry La Silla, Guadalupe , Guadalupe, Nuevo Leon MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

GRUPO YACANA MEXICO SAS DE CV
Date Published : 08/20/2020
Distrito B6 112 , Monterrey, MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Grupo Asimex de Mexico SA de CV
Date Published : 08/17/2020
Mario Pani No 750 Piso 10-C , Col. Santa Fe Cuajimalpa, Cuajimalpa De Morelos , Ciudad De Mexico, Ciudad de Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/17/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Grupo Insoma, S.A.P.I de CV
Date Published : 07/10/2020
Avenida Antonie Lavoisier # 31 , Cuautitlan Izcalli, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Grupo Plast-Y-Kosas, SA de CV
Date Published : 08/11/2020
Callejon Puebla 105-Co , Col. Rodriguez, Reynosa , Reynosa, Tamaulipas MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

HARMONIC NATURE S DE RL MI
Date Published : 08/20/2020
Calle Lacandon 205 , Unidad Habitacional Azteca, Guadalupe , Guadalupe, Nuevo Leon MEXICO
53 J - - 99 Other Personal Cleanliness Products (not Antiperspirant), N.E.C.
Date Published: 08/20/2020

Desc: All Drugs and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/20/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Healthy Foods & Nutrition Lab de Mexico S.A. de C.V.
Date Published : 08/13/2020
Calle Curtidores Num. 38 Zona Indistrial Xhala , Cuautitlan, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Ignacio Reyes Gonzalez
Date Published : 08/21/2020
Calle Independencia 416 , Col. Los Puestos, Tlaquepaque , Tlaquepaque, Jalisco MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Incredible Products, SA de CV
Date Published : 08/13/2020
Calle Castellanos Y Tapia 921 , Col. Santa Maria , Guadalajara, Jalisco MEXICO
53 E - - 06 Shampoos (Hair Preparations, Non-coloring)
Date Published: 08/13/2020

Desc: All Drugs and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

53 E - - 99 Other Hair Preparations, Non-coloring), N.E.C.
Date Published: 08/13/2020

Desc: All Drugs and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

53 J - - 01 Bath Soaps and Detergents (not Antiperspirant) (Personal Cleanliness)
Date Published: 08/13/2020

Desc: All Drugs and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Industrias Cklass S de RL de CV
Date Published : 09/14/2020
Avenida Ignacio L. Vallarta 4030 , Col. Vallarta, Guadalajara , Guadalajara, Jalisco MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/14/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Inovaker Lab SA de CV
Date Published : 10/02/2020
Calle Luis Quintanar 105 , Col. Bella Vista, Monterrey , Monterrey, Nuevo Leon MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 10/02/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Ismar Soluciones Dinamicas SA de CV
Date Published : 08/14/2020
Calle Industria Del Vestido 2153 , Industrial Zapopan Norte, Zapopan , Zapopan, Jalisco MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/14/2020

Notes: All Drug And Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

JG Atlas Comercios, SA de CV
Date Published : 08/07/2020
Calle Trueno Paraisos Delcolli 871 , Col. Paraisos Del Colli, Zapopan , Zapopan, Jalisco MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/07/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

JOSE MIGUEL GUTIERREZ SALAS
Date Published : 09/01/2020
Calle Higuera 66 , Tepic, MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/01/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Laboratorios Jaloma S.A. de C.V.
Date Published : 08/03/2020
Calle Aquiles Serdan No. 438 , Col. Oblatos, Guadalajara , Guadalajara, Jalisco MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/03/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Limpo Quimicos, SA de CV
Date Published : 07/15/2020
Privada Jose Silvestre Aramberri No. 149 , Col. Solidaridad, Gral. Escobedo , Ciudad General Escobedo, Nuevo Leon MEXICO
53 L - - 01 Cleansing (Cold Creams, Cleansing Lotions, Liquids, Pads) (Skin Care Preparations)
Date Published: 07/15/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Liq-E S.A. De C.V.
Date Published : 07/15/2020
Puerto Tampico 345 , San Nicolas De Los Georgia, FN MEXICO
53 J - - 99 Other Personal Cleanliness Products (not Antiperspirant), N.E.C.
Date Published: 07/15/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

MXL Comercial, SA de CV
Date Published : 07/24/2020
Calle Cromo No 206 , Col. Industrial Del Norte, Leon , Leon De Los Aldama, Guanajuato MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/24/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

MYM Hidrominerales S.A. de C.V.
Date Published : 08/27/2020
Avenida 5 De Mayo 600c , San Gregorio Atzompa , Chipilo De Francisco Javier Mina (Chipilo), Puebla MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/27/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Maquiladora Miniara Sa De Cv
Date Published : 07/16/2020
Crta. Teoloyucan Huehuetoca Km. 22 , Coyotepec , Coyotepec, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Marco Antonio Rodriguez Fierro
Date Published : 09/28/2020
Avenida Las Americas 409 , Col. Leon Xiii, Guadalupe , Guadalupe, Nuevo Leon MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/28/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Nanomateriales Sa De Cv
Date Published : 08/31/2020
Avenida Milimex 215 , Col. Milimex, Apodaca , Ciudad Apodaca, Nuevo Leon MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/31/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Neoingenium Labs, SA de CV
Date Published : 09/18/2020
Periferico Poniente Manuel Gomez Morin 6370 , Col. Ciudad Granja, Zapopan , Zapopan, Jalisco MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/18/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Notarika S.A. de CV
Date Published : 08/11/2020
Prolongacion 5 de Mayo 35 , Col. Parque Industrial , Naucalpan, MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Notarika, S.A. de C.V.
Date Published : 08/11/2020
Elctrica De Mxico No. 41 Vista Hermosa , Tlalnepantla De Baz , Tlalnepantla De Baz, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/11/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Noticias Mexico Hoy Grupo Multimedia, S.A. de C.V.
Date Published : 08/21/2020
Privada Rio Atoyac No.23 Puebla (Rancho Colorado ) , Puebla, MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/21/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

PLASTICOS LAS PALMAS S.A. DE C.V.
Date Published : 08/06/2020
Vereda De Las Violetasno 19 , Col. Los Sauces, Tlajomulco De Zuniga , Tlajomulco De Zuniga, Jalisco MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/06/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Precision Analitica Integral S.A. de C.V.
Date Published : 08/13/2020
Calle De Minas No. 501 Bodega 21 , Col. Arvide, Alvaro Obregon , Ciudad De Mexico, Ciudad de Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Quimica Magna de Mexico, S.A. de C.V.
Date Published : 07/15/2020
Calle La Aurora 130 , Col. Gustavo Espinoza Mireles, Saltillo , Saltillo, Coahuila de Zaragoza MEXICO
53 L - - 01 Cleansing (Cold Creams, Cleansing Lotions, Liquids, Pads) (Skin Care Preparations)
Date Published: 07/15/2020

Desc: All Drug and Drug Products
Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/15/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Real Clean Distribuciones SA de CV
Date Published : 07/16/2020
Recursos Petroleros , Fracc Industrial La Loma 3; Tlalnepantla De Baz , Tlalnepantla De Baz, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/16/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Roque Plast S.A. De C.V.
Date Published : 08/13/2020
Cda. Adolfo Manfredi No. 7ind. El , Atizapan De Zaragoza East, MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 08/13/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

Soluciones Cosmeticas, SA de CV
Date Published : 07/10/2020
Avenida Ano De Juarez 110 , Otro Granjas San Antonio, Iztapalapa , Ciudad De Mexico, Ciudad de Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

TROPICOSMETICOS SA DE CV
Date Published : 07/10/2020
Av Via Morelos No 60 Bodega 9 , Ecatepec, Mexico MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/10/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

YARA ELENA DE LA GARZA PEREZ NIETO
Date Published : 07/17/2020
Gustavo V 179. Puertas Del Rey , Saltillo , Saltillo, Coahuila de Zaragoza MEXICO
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 07/17/2020

Notes: All Drug and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.


TURKEY


Sck Zeta Dis Ticaret, Pazarlama Ltd.
Date Published : 09/22/2020
Buyukdere Cad. Kugu Is Hani No 81 K 1 D1 , Istanbul, Turkey, TURKEY
55 - - - -- Pharm Necess & Ctnr For Drug/Bio
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

56 - - - -- Antibiotics (Human/Animal)
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

60 - - - -- Human and Animal Drugs
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

61 - - - -- Human and Animal Drugs
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

62 - - - -- Human and Animal Drugs
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

63 - - - -- Human and Animal Drugs
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

64 - - - -- Human and Animal Drugs
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

65 - - - -- Human and Animal Drugs
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.

66 - - - -- Human and Animal Drugs
Date Published: 09/22/2020

Notes: All Drugs and Drug Products; All drug and drug products appear to be adulterated within the meaning of section 501(a)(2)(B) of the FD&C Act because the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements.